
A tumor that develops in the nasal cavity is called olfactory neuroblastoma, also known as esthesioneuroblastoma. The sensation of smell is produced by neurons and other tissue in the nasal cavity. This kind of tumor begins in the nasal cavity and can grow into the nearby eyes and brain. Olfactory neuroblastoma can potentially extend to other regions of the body, including the neck, lungs, and bones.
The following warning signs and symptoms could be markers of olfactory neuroblastoma. Watery eyes, nosebleeds, congestion or stuffiness that worsens or persists, nose obstruction, postnasal drip, or nasal discharge in the throat, and eye pain, pus from the nose, numbness in the face or teeth, loose teeth, diminished smell, or changes in eyesight, • Problem opening the mouth; • Pain or pressure in the ears; • Enlarged neck lymph nodes
Symptoms of olfactory neuroblastoma include:
Causes
The precise cause of olfactory neuroblastoma has not been determined by experts. Generally speaking, DNA alterations in cells cause cancer. The instructions that inform a cell what to do are encoded in its DNA. The modifications instruct the cells to rapidly produce a large number of new cells. When healthy cells would normally die, the alterations allow the cells to survive. Too many cells are produced as a result.
The cells may accumulate into a mass known as a tumor. Healthy body tissue may be invaded and destroyed by the tumor as it grows. Cells may eventually separate and disperse throughout the body.
Risk Factors
It is thought to be a major risk factor to work in areas where one is exposed to wood dust, metal dusts (nickel, cadmium), wheat, glues, formaldehyde, and other solvents. Olfactory neuroblastoma risk may also be raised by exposure to tobacco smoke.
Complications
The complications of Olfactory Neuroblastoma include:
Treatment for Olfactory Neuroblastoma (ON) has evolved significantly in Turkey thanks to interdisciplinary treatments, sophisticated radiation, and minimally invasive operations. Endoscopic endonasal surgery is used in hospitals to remove tumors precisely and with few side effects. While preserving healthy tissues, intensity-modulated radiation therapy (IMRT) aids in tumor targeting. Results are better when surgery, radiation, and chemotherapy are used together, particularly in more advanced instances.
Although the precise origin of olfactory neuroblastoma is unknown, evidence points to a possible connection with chemical exposure. People who are exposed to dangerous chemicals and particles at work or through other activities are more likely to develop malignancies of the nasal cavity, according to research. Wood dust, wheat, glues, nickel and cadmium dust, formaldehyde, and other solvents are a few potential offenders. The development of an olfactory neuroblastoma may potentially be influenced by tobacco smoke. Steer clear of these chemicals as much as you can to protect yourself.
Chemotherapy: Chemotherapy may be used in situations when the tumor has migrated to other body areas. The most often prescribed chemotherapeutic medications for neuroblastoma include vincristine, carboplatin, doxorubicin, cyclophosphamide, and cisplatin.Typically, chemotherapy is a systemic treatment. This implies that the medications enter the bloodstream and travel throughout the body to kill cancer cells, including ones that may have separated from the main tumor. The medications can be administered intravenously (IV) or orally. The medications may occasionally be administered safely using a specialized tool known as a central venous catheter. When chemotherapy begins, it is often implanted during surgery and kept there until the end of the course of treatment.
Cost Start From USD 7420 - USD 30000Explore Options
Radiation therapy: Some olfactory neuroblastoma tumors may be treated with radiation therapy. Radiation therapy may be used as the primary treatment or to help lower the likelihood of tumor recurrence following surgery. The success rates for radiation therapy are 90–95% in stage I, 85–90% in stage II, and 75–80% in stage III. The patient is recommended to see the doctor for follow-up every three months following radiation therapy.
Olfactory neuroblastoma is diagnosed by examining the nasal cavity using a number of various scanning techniques. These consist of MRIs, CT scans, and X-rays. A biopsy may be performed by a physician to obtain further information. To ascertain the type of cancer present, a tissue sample is taken and examined under a microscope.
Since neuroblastoma occurs near important structures, patients may require rehab for the following reasons.
Patients may experience changes in their sense of smell due to the tumor's proximity to the olfactory nerves, necessitating olfactory training or adaption techniques. Dryness in the nasal passages is one of the adverse effects of radiation therapy that may necessitate the adoption of extra management techniques. exercises to enhance the function of the muscles of the face, control pain, and encourage the repair of soft tissues. addressing any speech issues that can result from the disruption of surrounding structures after surgery. activities that aid in retraining the sense of smell, if it has been severely compromised. Advice on controlling nutritional requirements in light of possible swallowing issues
The only treatment option is surgery, radiation therapy, and chemotherapy. The most often prescribed chemotherapeutic medications for neuroblastoma include vincristine, carboplatin, doxorubicin, cyclophosphamide, and cisplatin.









Istanbul, Turkey
The first green hospital in Turkey, Istanbul Florence Nightingale Hospital, was inaugurated in 2013. Group The Florence Nightingale hospitals are the first Turkish hospitals to be granted Joint Commission International (JCI) accreditation, and they continue to be associated and work with esteemed healthcare organizations.
The Florence Nightingale Group treats 250,000 outpatients and 70,000 inpatients annually, demonstrating its excellence. The hospitals have a capacity of 804 inpatient beds, 141 ICU beds, and 40 operating rooms, and perform 20,000+ procedures annually, of which 1,000 are cardiac operations for children and 2,000 are for adults. For conducting difficult orthopedic, general surgery, minimally invasive, and other heart treatments, the facility stands out. All operating rooms can be interconnected by audio-visual to a 300-person conference room and global hubs, enabling interactive medical teaching and scientific activity.
Interpreter and translator services for languages such as Turkish, Azerbaijani, Bulgarian, Arabic, English, Persian, Serbian, Russian, Albanian, Macedonian, German, Bosnian, and Romanian are available.
The hospital has specialized departments such as Cardiology and Cardiac Surgery, IVF and Infertility, Nephrology, Oncology and Oncosurgery, Spine Surgery, Neurology and Neurosurgery, Orthopedics, Gynecology, and Obesity or Bariatric Surgery. With an extensively qualified and experienced team of advisors and interpreters, Florence Nightingale Istanbul is committed to providing one-stop service from beginning to end, 24 hours a day, 7 days a week.

Istanbul, Turkey
Medipol Bahcelievler Hospital is a medical institution providing a full range of medical and individualized approaches to its patients. Medipol has the ambition to bring high quality and maximum security to people in need by employing state-of-the-art technologies in medicine. They ensure that the health of the patients is improved by fashioning unique physician specialty treatment programs.
Medipol Bahcelievler Hospital provides an exceptional position in the healthcare industry with a policy of clear communication, professionalism, and reliability to patient expectations. Medipol Bahçelievler Hospital is situated in the European Side of Istanbul, dedicated to 24-hour health care for you and your loved ones, equipped with a fully functional operation theatre and ICUs with state-of-the-art equipment, laboratory, emergency, and advanced treatment rooms

Istanbul, Turkey
Acibadem Altunizade Hospital located in Istanbul, Turkey is accredited by JCI. Also listed below are some of the most prominent infrastructural details:
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Here are some of the reasons for choosing Turkey:
Due to advancements in medical facilities, such as minimally invasive surgical techniques.
Yes, a group of specialists including radiation oncologists, neurosurgeons, and head and neck surgeons collaborate to create a customized treatment plan for each patient. With treatment, the majority of patients with olfactory neuroblastoma recover.
In Turkey, modern radiation (IMRT), interdisciplinary care, and minimally invasive endoscopic surgery are all very efficient ways to treat olfactory neuroblastoma (ON).
Yes, many Turkish hospitals offer the following for olfactory neuroblastoma treatment:
Always consider the following factors when selecting a hospital in Turkey:
In Turkey, olfactory neuroblastoma (ON) treatment has a good success rate, particularly when early detection and cutting-edge techniques like IMRT and endoscopic surgery are used.
You need to keep an eye out for the following signs in them:
Patients with Olfactory Neuroblastoma may experience long-term consequences such as irreversible loss of smell (anosmia), changes in vision, cognitive impairment, and the possibility of spread of tumor to other parts of the body.
Yes, you can see top neuro hospitals and doctors in Turkey for a second opinion on Olfactory Neuroblastoma treatment. Numerous prestigious medical facilities consult with skilled doctors who will examine your diagnosis and suggest the best course of action.